Search For "glenmark pharmaceuticals"
Glenmark receives one ANDA approval and two tentative ANDA approva
Updated : 3 weeks, 4 days ago IST
Mumbai (Maharashtra)[India], December 31 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 2
Read More
Glenmark becomes the first company to launch Remogliflozin + Vilda
Updated : 3 weeks, 6 days ago IST
Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of its novel, patent protected and globally researched Sodium Glucose Co-Transporter Inhibitor (
Read More
Glenmark Pharmaceuticals and Menarini enter into exclusive licensi
Updated : 1 month ago IST
Mumbai (Maharashtra) [India] December 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, has entered into an exclusive licensing agreement with Menarini Group
Read More
Glenmark Pharmaceuticals receives ANDA tentative approval for Dabi
Updated : 1 month ago IST
Mumbai (Maharashtra) [India], December 21 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg, the generic version of Pradaxa®
Read More
Glenmark to divest select Anti-Allergy brands to Dr Reddy's in Rus
Updated : 1 month, 3 weeks ago IST
Mumbai (Maharashtra) [India], November 29 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. today announced that it has entered into a definitive agreement with Dr. Reddy's Laboratories Ltd. to divest - subject to completion of certain precedent actions and closing activities - its brand Mo
Read More
Glenmark Pharmaceuticals secures its position in the prestigious D
Updated : 2 months ago IST
Mumbai (Maharashtra) [India], November 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets
Read More
Recently published data on Favipiravir as treatment for mild to mo
Updated : 2 months ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Cap
Updated : 2 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], November 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf®1 C
Read More
Glenmark announces Q2 FY20-21 results
Updated : 2 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], November 7 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the second quarter ended Sept 30, 2020.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tabl
Updated : 3 months, 1 week ago IST
Mumbai (Maharashtra) [India], Oct 19 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune®1 Tablets, 0.5 mg, 1
Read More
Glenmark introduces NINDANIB (Nintedanib) and is amongst the first
Updated : 3 months, 1 week ago IST
Mumbai (Maharashtra) [India], October 14 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched NINDANIB (Nintedanib 100 and 150 mg capsules) for the treatment of pulmonary fibrosis in India.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumar
Updated : 3 months, 2 weeks ago IST
Mumbai (Maharashtra) [India] October 7 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg, the generic version of Tecfide
Read More